BioMarin Pharmaceutical Inc. (BMV:BMRN)

MorphoSys AG Statistics

Total Valuation

BMV:BMRN has a market cap or net worth of MXN 213.61 billion. The enterprise value is 198.11 billion.

Market Cap	213.61B
Enterprise Value	198.11B

Important Dates

The last earnings date was Friday, August 1, 2025.

Earnings Date	Aug 1, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	192.01M
Shares Outstanding	n/a
Shares Change (YoY)	+0.35%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	179.60M

Valuation Ratios

The trailing PE ratio is 17.23 and the forward PE ratio is 13.23.

PE Ratio	17.23
Forward PE	13.23
PS Ratio	3.70
PB Ratio	1.88
P/TBV Ratio	2.03
P/FCF Ratio	16.30
P/OCF Ratio	14.77
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.92, with an EV/FCF ratio of 15.12.

EV / Earnings	15.98
EV / Sales	3.46
EV / EBITDA	10.92
EV / EBIT	12.14
EV / FCF	15.12

Financial Position

The company has a current ratio of 5.56, with a Debt / Equity ratio of 0.10.

Current Ratio	5.56
Quick Ratio	3.34
Debt / Equity	0.10
Debt / EBITDA	0.62
Debt / FCF	0.87
Interest Coverage	78.64

Financial Efficiency

Return on equity (ROE) is 11.62% and return on invested capital (ROIC) is 8.37%.

Return on Equity (ROE)	11.62%
Return on Assets (ROA)	7.50%
Return on Invested Capital (ROIC)	8.37%
Return on Capital Employed (ROCE)	12.88%
Revenue Per Employee	19.00M
Profits Per Employee	4.08M
Employee Count	3,040
Asset Turnover	0.42
Inventory Turnover	0.44

Taxes

In the past 12 months, BMV:BMRN has paid 3.45 billion in taxes.

Income Tax	3.45B
Effective Tax Rate	21.76%

Stock Price Statistics

The stock price has decreased by -23.32% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.32%
50-Day Moving Average	1,633.45
200-Day Moving Average	1,658.34
Relative Strength Index (RSI)	39.95
Average Volume (20 Days)	146

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.69

Income Statement

In the last 12 months, BMV:BMRN had revenue of MXN 57.77 billion and earned 12.39 billion in profits. Earnings per share was 64.10.

Revenue	57.77B
Gross Profit	47.26B
Operating Income	16.44B
Pretax Income	15.84B
Net Income	12.39B
EBITDA	18.01B
EBIT	16.44B
Earnings Per Share (EPS)	64.10

Balance Sheet

The company has 27.01 billion in cash and 11.39 billion in debt, giving a net cash position of 15.62 billion.

Cash & Cash Equivalents	27.01B
Total Debt	11.39B
Net Cash	15.62B
Net Cash Per Share	n/a
Equity (Book Value)	113.66B
Book Value Per Share	591.98
Working Capital	58.86B

Cash Flow

In the last 12 months, operating cash flow was 14.46 billion and capital expenditures -1.36 billion, giving a free cash flow of 13.10 billion.

Operating Cash Flow	14.46B
Capital Expenditures	-1.36B
Free Cash Flow	13.10B
FCF Per Share	n/a

Margins

Gross margin is 81.80%, with operating and profit margins of 28.46% and 21.45%.

Gross Margin	81.80%
Operating Margin	28.46%
Pretax Margin	27.42%
Profit Margin	21.45%
EBITDA Margin	31.18%
EBIT Margin	28.46%
FCF Margin	22.68%

Dividends & Yields

BMV:BMRN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.35%
Shareholder Yield	n/a
Earnings Yield	5.80%
FCF Yield	6.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BMV:BMRN has an Altman Z-Score of 6.89 and a Piotroski F-Score of 7.

Altman Z-Score	6.89
Piotroski F-Score	7